Paclitaxel-13C6（Cat No.:R021657） is a high-purity, isotopically labeled compound essential for advanced pharmaceutical and biochemical research. Incorporating six 13C atoms, this stable isotope-labeled version of Paclitaxel is critical for studying drug metabolism, pharmacokinetics, and cancer research. Its precise labeling allows for accurate tracking and quantification in complex biological systems, ensuring reliable and reproducible analytical results.Paclitaxel-13C6 is an invaluable tool for scientific investigations and drug development.
| Catalog Number | R021657 |
| CAS Number | NA |
| Synonyms | Abraxane-13C6; Genaxol-13C6; Genetaxyl-13C6; OncoGel-13C6; Onxal-13C6; Pacliex-13C6; (-)-Paclitaxel-13C6; Taxol-13C6; Yewtaxan-13C6; NSC 125973-13C6; |
| Molecular Formula | C₄₁¹³C₆H₅₁NO₁₄ |
| Purity | ≥95% |
| Storage | 3 years -20C powder |
| IUPAC Name | [(1S,2S,3S,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2S,3R)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] (1,2,3,4,5,6-13C6)cyclohexatrienecarboxylate |
| InChI | InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35+,36-,37+,38+,40-,45+,46-,47+/m0/s1/i9+1,14+1,15+1,20+1,21+1,30+1 |
| InChIKey | RCINICONZNJXQF-IEMAKSHKSA-N |
| SMILES | CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@H]([C@@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)[13C]7=[13CH][13CH]=[13CH][13CH]=[13CH]7)(CO4)OC(=O)C)O)C)OC(=O)C |
